Women's Health

Is Screening for Ovarian Cancer Cost-Effective?

Earlier detection could be possible

Usha Menon, MD, is a UKCTOCS co principal investigator and trial coordinator at University College London, and she stated the importance of such an investigation, "there is currently no national screening program for ovarian cancer, as research to date has been unable to provide enough evidence that any one method would improve early detection of tumors. Their results are therefore very encouraging. They show that use of an early detection strategy based on an individual's CA-125 profile significantly improved cancer detection compared to what we've seen in previous screening trials."

They estimated that when people are willing to pay $150,000 per an added year to their life, the MMS beginning at age 50 is cost-effective around 70 percent of the time. Of course, this statistic accounted for uncertainty regarding varying circumstances as well.